http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03070154-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_29ce56cbea26df5a925f28fa3b878eae
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
filingDate 2003-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fd91654c6d2736a48b04a3a39d8d369
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83dcbe0dc63dfa58d9844fe751756b79
publicationDate 2004-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-03070154-A3
titleOfInvention Orally administrable pharmaceutical formulation comprising pseudoephedrine hydrochloride and process for preparing the same
abstract Disclosed are pharmaceutical formulations for oral administration through a soft gelatin capsule drug delivery device, wherein the pharmaceutical formulation, in a preferred embodiment, contains Pseudoephedrine HCl and an expectorant as the active ingredients. The active pharmaceutical ingredient is embedded into an oily matrix. The formulation also includes an expectorant; a surfactant; a suspending agent; and a suspension medium, wherein, in a preferred embodiment, the expectorant is guaifenesin, the surfactant is lecithin, the suspending agent is yellow beeswax, and the suspension medium is soybean oil. In a preferred embodiment, the formulation consists essentially of about 30.5 mg by weight of Pseudoephedrine HCI, about 200 mg by weight of guaifenesin, about 0.1- 5.0 mg by weight of yellow beeswax, about 10-15 mg by weight of lecithin; and about 200-300 mg by weight of soybean oil. Also disclosed is a process for preparing the formulation.
priorityDate 2002-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5595758-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4797288-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4716033-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5032
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396380
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396343
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396381
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8648
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6604218
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411746
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226419982

Total number of triples: 28.